Lifecore Biomedical (LFCR) Misses Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts LFCR Hot Sheet
Join SI Premium – FREE
Lifecore Biomedical (NASDAQ: LFCR) reported Q2 EPS of ($0.06), $0.02 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $36.44 million versus the consensus estimate of $35.36 million.
For earnings history and earnings-related data on Lifecore Biomedical (LFCR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Arbor Realty Trust (ABR) Tops Q2 EPS by 4c
- Quanta Services (PWR) PT Raised to $748 at Bernstein SocGen Group
- Regal-Beloit (RBC) Tops Q1 EPS by 47c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
